文献速递临床试验与 GCP

远程缺血调理治疗感染性休克(RECO-Sepsis):一项随机对照试验的研究方案

Remote ischemic conditioning in septic shock (RECO-Sepsis): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2019-05-22

RECO-Sepsis是一项正在进行的前瞻性、多中心、随机、开放标签试验,旨在检验远程缺血调理(RECO)作为感染性休克常规治疗的辅助疗法能否降低多器官衰竭的严重程度,以序贯器官衰竭评估(SOFA)评分衡量。计划纳入180例成人感染性休克患者,1:1随机接受RECO或不接受辅助干预,主要终点为入组后至第4天的每日平均SOFA评分。

要点

  • RECO由四个循环的袖带充气至200 mmHg持续5分钟、再放气至0 mmHg持续5分钟组成。
  • RECO在入组时进行,并在12小时和24小时后重复。
  • 主要终点为入组后至第4天的每日平均SOFA评分。

核心结论

  • 该概念验证试验的结果应能提供RECO在感染性休克患者中疗效的信息。

研究设计与样本

  • RECO-Sepsis是一项正在进行的前瞻性、多中心、随机、开放标签试验,计划纳入180例患者,1:1随机接受RECO或不接受辅助干预。
  • 纳入标准:入住重症监护室、有明确或疑似感染、乳酸血症>2 mmol/l、接受去甲肾上腺素治疗不足12小时的成人患者。
  • 排除标准:已表达不希望被复苏的意愿、双臂均禁忌使用肱动脉袖带、合并预期寿命不足24小时的疾病、心脏骤停、妊娠或哺乳期女性。

主要发现

  • 主要终点为入组后至第4天的每日平均SOFA评分。
  • 次要结局包括器官支持需求、住院时长和90天死亡率。

关键数值与推荐

  • RECO方案为四个循环的袖带充气至200 mmHg持续5分钟、再放气至0 mmHg持续5分钟。
  • RECO在入组时进行,并在12小时和24小时后重复。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Septic shock is a major public health problem that is associated with up to 50% mortality. Unfavorable outcomes are mainly attributed to multiple organ failure (MOF) resulting from an uncontrolled inflammatory response and ischemia-reperfusion processes. REmote ischemic COnditioning (RECO) is a promising intervention to prevent ischemia-reperfusion injury. We hypothesize that RECO would reduce the severity of septic shock-induced MOF. METHODS/DESIGN: RECO in septic shock patients (RECO-Sepsis study) is an ongoing, prospective, multicenter, randomized, open-label trial, testing whether RECO, as an adjuvant therapy to conventional treatment in septic shock, decreases the severity of MOF as assessed by the Sequential Organ Failure Assessment (SOFA) score. Adult patients admitted to an intensive care unit with documented or suspected infection, lactatemia > 2 mmol/l, and treated with norepinephrine for less than 12 h are potentially eligible for the study. Non-inclusion criteria are: having expressed the wish not to be resuscitated, contraindication for the use of a brachial cuff on both arms, intercurrent disease with an expected life expectancy of less than 24 h, cardiac arrest, and pregnant or breastfeeding women. After enrollment, patients are randomized (n = 180) 1:1 to receive RECO or no adjunctive intervention. RECO consists of four cycles of cuff inflation to 200 mmHg for 5 min and then deflation to 0 mmHg for another 5 min. RECO is performed at inclusion and repeated 12 and 24 h later. The primary endpoint is the mean daily SOFA score up to day 4 after inclusion. Secondary outcomes include the need for organ support, hospital length of stay, and 90-day mortality. DISCUSSION: Results of this proof-of-concept trial should provide information on the efficacy of RECO in patients with septic shock. TRIAL REGISTRATION: ClinicalTrials.gov, ID: identifier: NCT03201575 . Registered on 28 June 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Cour M, Buisson M, Klouche K, et al. Remote ischemic conditioning in septic shock (RECO-Sepsis): study protocol for a randomized controlled trial. Trials. 2019. PMID: 31118101. doi:10.1186/s13063-019-3406-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。